Copyright ©The Author(s) 2015.
World J Hepatol. Mar 27, 2015; 7(3): 539-547
Published online Mar 27, 2015. doi: 10.4254/wjh.v7.i3.539
Figure 1
Figure 1 Algorithm suggested for the management of patients with inflammatory diseases and hepatitis B virus infection. 1Except Rituximab, in which antiviral prophylaxis is desirable; 2Low dose steroids ≤ 20 mg/d prednisone. Adapted from Lopez-Serrano et al[17]. ID: Inflammatory diseases; IS: Immunosuppressants (steroids, thiopurines, methotrexate and biologics); NAs: Nucleoside/nucleotide analogues; HBcAb: Hepatitis B core antibody; HBsAg: Hepatitis B surface antigen; Low biodisponibility steroids: Budesonide or beclometasone dipropionate; HBV: Hepatitis B virus.